A smaller study evaluating the effect of liraglutide on heart failure and natriuretic peptides in participants with and without T2D found a significant 25% reduction in NT-pro-BNP in participants with T2D but not in those without T2D [40]. The gene discussed is NPPB; the disease is type 2 diabetes mellitus.